Health · 1 views
Preclinical study points to cancer drugs as possible treatments for chronic nerve pain
BRAF inhibitors reduced pain sensitivity in preclinical models, suggesting the therapeutic potential of this approach for treating chronic nerve pain.
AI Summary
Researchers at The University of Texas MD Anderson Cancer Center identified the protein BRAF, typically linked to cancer, as a critical factor in the development, amplification, and maintenance of chronic nerve‑damage pain. This preclinical finding suggests that drugs targeting BRAF could be repurposed for treating chronic neuropathic pain.
Read full article on Medical XpressAI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- The bridges of Rwanda open up new worldsContinue reading
- Lights out, Instagram off? The changes to Meta for teens could be a big dealContinue reading
- Trump cuts to science advisory boards have long-lasting consequences, researchers sayContinue reading
- FDA authorizes first wearable to track both ketones and blood sugarContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow